Henry Schein Dental Company is a leading provider of dental products and services, catering primarily to dental professionals and practices. The company offers a comprehensive range of solutions including dental equipment, consumable supplies, technology products, and practice management tools. In addition to its product offerings, Henry Schein Dental also provides training and support services, helping dental practitioners enhance their operations and improve patient care. With a strong emphasis on innovation and customer service, the company plays a vital role in advancing the dental industry and supporting the success of dental health providers. Read More
The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements.
Dental and medical products company Henry Schein (NASDAQ:HSIC) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 5.2% year on year to $3.34 billion. Its GAAP profit of $0.84 per share was 16.9% below analysts’ consensus estimates.
Henry Schein Q3 2025 earnings beat profit estimates, driving a 7% stock surge. The company also raised its full-year EPS guidance, signaling strong operational momentum.
Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results for the third quarter ended September 27, 2025.
Henry Schein One, a leading global provider of dental technology, today announced a groundbreaking partnership with Amazon Web Services (AWS), the world’s most comprehensive and broadly adopted cloud platform. Together, the companies will integrate AWS’s generative AI (GenAI) technologies across the Henry Schein One platform — including Dentrix, Dentrix Ascend, and Dentally — to usher in a new era of AI-powered dentistry.
Dental and medical products company Henry Schein (NASDAQ:HSIC)
will be reporting results this Tuesday before market open. Here’s what you need to know.
Henry Schein, Inc., (Nasdaq: HSIC) the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conferences in November:
Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that it will release its third quarter 2025 financial results before the stock market opens on Tuesday, November 4, 2025, and will provide a live webcast of its earnings conference call on the same day beginning at 8:00 a.m. Eastern time. Speakers on the call will include Stanley M. Bergman, Chairman of the Board and Chief Executive Officer, and Ronald N. South, Senior Vice President and Chief Financial Officer.
Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices.
But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.
Henry Schein currently trades at $64.88 per share and has shown little upside over the past six months, posting a middling return of 3.5%. The stock also fell short of the S&P 500’s 34.7% gain during that period.
Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Monday to uncover the stocks that are gapping in the S&P500 index.
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages.
Just because a business is in the green today doesn’t mean it will thrive tomorrow.
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance.
Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.
Shares of dental and medical products company Henry Schein (NASDAQ:HSIC)
fell 2.7% in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential tariffs.
Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care products and services to office-based dental and medical practitioners, announced today that its Board of Directors has authorized the repurchase of up to $750 million of shares of the Company's common stock.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at dental equipment & technology stocks, starting with Henry Schein (NASDAQ:HSIC).
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner.
Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.
Henry Schein, Inc., the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conferences in September:
